(BCSF) Bain Capital Specialty - Ratings and Ratios
Senior Loans, Mezzanine Debt, Unitranche, Second Lien, Junior Securities
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 18.2% |
| Value at Risk 5%th | 31.2% |
| Relative Tail Risk | 4.33% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.43 |
| Alpha | -18.58 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.502 |
| Beta | 0.744 |
| Beta Downside | 0.802 |
| Drawdowns 3y | |
|---|---|
| Max DD | 25.79% |
| Mean DD | 6.40% |
| Median DD | 3.71% |
Description: BCSF Bain Capital Specialty November 17, 2025
Bain Capital Specialty Finance, Inc. (NYSE: BCSF) operates as a Business Development Company that originates and acquires direct loans to U.S. middle-market companies. Its investment mandate covers a spectrum of senior secured structures-including first-lien, second-lien, stretch senior, unitranche, and mezzanine debt-as well as secondary purchases of existing corporate-debt portfolios. The firm typically targets borrowers with EBITDA ranging from $10 million to $150 million, positioning itself in a credit tier that balances higher yields with manageable default risk.
Key performance indicators that analysts watch for BCSF include its loan portfolio size (approximately $1.2 billion as of the latest filing), net interest margin (historically around 6-7 % after fees), and weighted-average loan-to-value (LTV) of roughly 70 %. Macro-level drivers such as the Federal Reserve’s interest-rate policy and the health of the U.S. middle-market economy materially affect both deal flow and credit quality; a tightening cycle can compress spreads but also increase demand for alternative financing, while a slowdown in EBITDA growth may elevate delinquency rates. The asset-management sub-industry’s regulatory environment-particularly BDC-specific capital-structure rules-adds another layer of operational constraint that can influence leverage ratios and dividend policy.
For a deeper, data-rich assessment of BCSF’s valuation dynamics, you may find ValueRay’s proprietary credit-risk analytics platform useful as a next step in your research.
BCSF Stock Overview
| Market Cap in USD | 900m |
| Sub-Industry | Asset Management & Custody Banks |
| IPO / Inception | 2018-11-15 |
| Return 12m vs S&P 500 | -17.0% |
| Analyst Rating | 3.67 of 5 |
BCSF Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 16.33% |
| Yield on Cost 5y | 32.75% |
| Yield CAGR 5y | 14.62% |
| Payout Consistency | 92.9% |
| Payout Ratio | 97.8% |
BCSF Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 12.58% |
| CAGR/Max DD Calmar Ratio | 0.49 |
| CAGR/Mean DD Pain Ratio | 1.97 |
| Current Volume | 716.2k |
| Average Volume | 353.4k |
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (107.2m TTM) > 0 and > 6% of Revenue (6% = 12.4m TTM) |
| FCFTA -0.01 (>2.0%) and ΔFCFTA -1.95pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 1.00% (prev -0.35%; Δ 1.36pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.01 (>3.0%) and CFO -17.6m <= Net Income 107.2m (YES >=105%, WARN >=100%) |
| Net Debt (-67.0m) to EBITDA (44.5m) ratio: -1.51 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.02 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (64.9m) change vs 12m ago 0.47% (target <= -2.0% for YES) |
| Gross Margin 83.69% (prev 92.26%; Δ -8.56pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 7.84% (prev 8.81%; Δ -0.98pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.43 (EBITDA TTM 44.5m / Interest Expense TTM 81.9m) >= 6 (WARN >= 3) |
Altman Z'' 0.24
| (A) 0.00 = (Total Current Assets 104.3m - Total Current Liabilities 102.2m) / Total Assets 2.72b |
| (B) -0.01 = Retained Earnings (Balance) -35.6m / Total Assets 2.72b |
| (C) 0.04 = EBIT TTM 117.5m / Avg Total Assets 2.63b |
| (D) -0.02 = Book Value of Equity -35.5m / Total Liabilities 1.59b |
| Total Rating: 0.24 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 45.28
| 1. Piotroski 2.0pt |
| 2. FCF Yield -0.79% |
| 3. FCF Margin -8.55% |
| 4. Debt/Equity 1.23 |
| 5. Debt/Ebitda -1.51 |
| 6. ROIC - WACC (= 0.07)% |
| 7. RoE 9.42% |
| 8. Rev. Trend -32.42% |
| 9. EPS Trend -17.06% |
What is the price of BCSF shares?
Over the past week, the price has changed by -0.65%, over one month by -1.64%, over three months by -7.36% and over the past year by -7.15%.
Is BCSF a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BCSF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 15.2 | 10.1% |
| Analysts Target Price | 15.2 | 10.1% |
| ValueRay Target Price | 16.6 | 20.4% |
BCSF Fundamental Data Overview November 15, 2025
P/E Trailing = 9.6319
P/E Forward = 10.3842
P/S = 3.2324
P/B = 0.8053
P/EG = 1.0697
Beta = 0.636
Revenue TTM = 206.1m USD
EBIT TTM = 117.5m USD
EBITDA TTM = 44.5m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 1.39b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -67.0m USD (from netDebt column, last quarter)
Enterprise Value = 2.22b USD (899.7m + Debt 1.39b - CCE 67.0m)
Interest Coverage Ratio = 1.43 (Ebit TTM 117.5m / Interest Expense TTM 81.9m)
FCF Yield = -0.79% (FCF TTM -17.6m / Enterprise Value 2.22b)
FCF Margin = -8.55% (FCF TTM -17.6m / Revenue TTM 206.1m)
Net Margin = 52.00% (Net Income TTM 107.2m / Revenue TTM 206.1m)
Gross Margin = 83.69% ((Revenue TTM 206.1m - Cost of Revenue TTM 33.6m) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 80.05%)
Tobins Q-Ratio = 0.82 (Enterprise Value 2.22b / Total Assets 2.72b)
Interest Expense / Debt = 1.46% (Interest Expense 20.3m / Debt 1.39b)
Taxrate = 2.67% (801.0k / 30.0m)
NOPAT = 114.3m (EBIT 117.5m * (1 - 2.67%))
Current Ratio = 1.02 (Total Current Assets 104.3m / Total Current Liabilities 102.2m)
Debt / Equity = 1.23 (Debt 1.39b / totalStockholderEquity, last quarter 1.13b)
Debt / EBITDA = -1.51 (Net Debt -67.0m / EBITDA 44.5m)
Debt / FCF = 3.81 (negative FCF - burning cash) (Net Debt -67.0m / FCF TTM -17.6m)
Total Stockholder Equity = 1.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.95% (Net Income 107.2m / Total Assets 2.72b)
RoE = 9.42% (Net Income TTM 107.2m / Total Stockholder Equity 1.14b)
RoCE = 4.49% (EBIT 117.5m / Capital Employed (Total Assets 2.72b - Current Liab 102.2m))
RoIC = 4.38% (NOPAT 114.3m / Invested Capital 2.61b)
WACC = 4.30% (E(899.7m)/V(2.29b) * Re(8.76%) + D(1.39b)/V(2.29b) * Rd(1.46%) * (1-Tc(0.03)))
Discount Rate = 8.76% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 0.24%
Fair Price DCF = unknown (Cash Flow -17.6m)
EPS Correlation: -17.06 | EPS CAGR: 7.38% | SUE: -0.03 | # QB: 0
Revenue Correlation: -32.42 | Revenue CAGR: -5.56% | SUE: -0.29 | # QB: 0
Additional Sources for BCSF Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle